See your results below for :
Cimerli 1ML of 0.5MG/0.05ML : Vial - 2

Cimerli Coupons & Prices

What is Cimerli ?

Cimerli (Ranibizumab-eqrn) is a biosimilar to Lucentis, primarily indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) and macular edema. As an anti-VEGF (vascular endothelial growth factor) agent, it works by inhibiting abnormal blood vessel growth and leakage in the eye, thereby preserving vision.

Cimerli

ra-ni-BIZ-oo-mab

Consumer Forms
Implant , Injectable

Consumer Routes
Into the eye

Therapeutic Classes
Ophthalmologic Agent

  • Irritated, dry, or watery eyes, a feeling that something is in your eyes
  • Eye pain, swelling, redness, or itching of your eyes or eyelids
  • Bleeding in your eye
  • Irritated, dry, or watery eyes, a feeling that something is in your eyes
  • Blurred vision, seeing floating spots, sensitivity to light
  • Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
  • Chest pain that may spread, trouble breathing, nausea, unusual sweating, faintness
  • Numbness or weakness in your arm or leg, or on one side of your body, pain in your lower leg (calf)
  • Sudden or severe headache, problems with vision, speech, or walking
  • Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments.
  • It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. Use an effective form of birth control during treatment with this medicine and for at least 12 months after the last dose.
  • Tell your doctor if you are breastfeeding, or if you have glaucoma, an eye infection, other eye problems, or bleeding problems.
  • This medicine may cause the following problems:Serious eye or vision problems (including eye infection or bleeding, retinal detachment, conjunctival bleb, erosion, retinal vasculitis with or without occlusion, or retraction)Increased risk of blood clots, heart attack, or stroke
  • Tell your doctor right away if your implant has moved out of place. You may need a surgery to correct this movement.
  • Implant damage may occur with Susvimo„¢, which may cause problems when you receive a refill. Your doctor may remove the implant or change your treatment if your implant has been damaged.
  • Tell your doctor that you have Susvimo„¢ implanted in your eye before you have an MRI.
  • Do not drive or do anything else that could be dangerous until your eye shield can be removed and you can see. Do not rub or touch the area of the eye where the implant is inserted. Wash your hands first, if you have to touch your eye.
¿Buscando esta página en español?

Related Drugs


Don't Miss Out On Savings!


Rx.com does not warrant the accuracy of the information on this website. All information on this site is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of a drug is safe, appropriate, or effective for you. Consult your healthcare professional before using any drug. All logos, brand names and trademarks on this website are the property of their respective owners. Rx.com is not endorsed or affiliated with any brands represented on this website."

Pharmacy discounts are Not Insurance, and are Not Intended as a Substitute for Insurance THE DISCOUNT IS ONLY AVAILABLE AT PARTICIPATING PHARMACIES 2023 All Rights Reserved | Rx.com®